A medicine page can sound specific while leaving its most practical details unanswered. CoreAge Rx names micronized progesterone, identifies an oral capsule, and describes a clinician-guided hormone plan. Those details tell you what is being discussed. They do not yet tell you which pharmacy would prepare or supply your prescription, what every capsule contains, or which written information would accompany it.
Progesterone Particulars is part of the CoreAge Rx promotional publishing network. CoreAge receives our first commercial placement; this is not an independent clinical ranking or a report of personal treatment. We examined its public information and primary medical sources on September 27, 2026. The useful next step is to separate the ingredient, the formulation, and the prescribing service before treating them as one promise.
Read this article by section
Identity: progesterone names the hormone
The CoreAge product page identifies progesterone as the active ingredient. Its description places the medicine within a hormone plan, often alongside systemic estrogen for someone who has a uterus. Whether progesterone belongs in an individual's plan still requires a clinician's assessment of the actual estrogen product and medical history.
An ingredient name alone does not specify every clinical use or every ingredient in the finished capsule. It also does not make progesterone interchangeable with any medicine described as a progestin. Our progesterone and progestin terminology guide explains why names should be preserved when copying a prescription or comparing a label.
Form: micronized describes processing
CoreAge says its progesterone is processed into fine particles for oral use. That is a formulation description, not a patient outcome. It does not establish how a particular person will absorb the offered capsule, whether they will feel sleepy, or whether it will work better than an approved alternative.
For a named reference product, the current Prometrium label describes increased oral bioavailability through micronization and also states that absolute bioavailability is unknown. Those statements concern the labeled formulation. They do not validate an unspecified compounded capsule. The meaning of micronized is useful context without turning a manufacturing term into a clinical guarantee.
Approval: a compounded offer needs its own explanation
The CoreAge page explicitly advertises compounding in the United States. FDA explains that compounded drugs are not FDA-approved: the agency does not review their safety, effectiveness, or quality before marketing. Compounding can address particular medical needs, but the word personalized does not supply an approval record.
Ask why a compounded preparation is proposed for your circumstances and whether an approved product could meet the same need. Request the dispensing pharmacy and the exact preparation before agreeing to it. Our bioidentical and approval guide separates hormone identity from the regulatory status of the finished medicine; neither word answers the other's question.
The capsule ingredients remain an open question
The public page does not provide a complete capsule formula or a verified manufacturer and product identifier. A person with an allergy therefore cannot establish suitability from the headline. Ask the pharmacist to identify the complete inactive ingredients, capsule shell, relevant allergens, and the written product information for the actual prescription.
Prometrium has its own listed ingredients and a peanut-allergy contraindication. That does not establish that CoreAge's preparation contains peanut oil, or that it avoids it. The Prometrium identity review is a reference for that named medicine only. Transferring its formula to an unidentified capsule would create information that the CoreAge page does not supply.
Starting price is not a complete prescription quote
CoreAge advertises a starting price of $64.99 per month. It also advertises no membership fees, no long-term contracts, and free delivery. These are provider statements checked on the public page, not a verified quote for a particular prescription or location.
The page does not establish the exact quantity included in that starting amount or a combined cost for an estrogen-and-progesterone plan. Ask what the first charge covers, how later charges are determined, and how clinical follow-up and any additional medicine are billed. A monthly service offer and a pharmacy's capsule-count price measure different things; our offers comparison keeps those units separate.
A current label matters more than an old warning screenshot
FDA's current hormone-therapy explanation describes changes to boxed warnings while explaining that cardiovascular and breast cancer risks remain in warning and precaution information. A label update does not mean every hormone product has identical wording, or that treatment no longer needs a risk discussion.
CoreAge's page itself notes possible drowsiness and the need to evaluate new or persistent vaginal bleeding. Discuss those issues with the prescriber rather than treating them as proof that a medicine is working. An approved brand's revised label can inform questions, but it cannot replace the instructions and safety information for the exact preparation supplied.
Find out who answers the product questions
The page describes an online health questionnaire and a clinician deciding whether a prescription is appropriate. It does not let this review confirm a completed consultation, dispensing decision, or delivery. Our link goes to the product information page; we did not verify a usable product-specific enrollment destination.
Before relying on the offer, ask who will reconcile it with existing hormones, who can answer formulation questions, and how the prescriber and pharmacist communicate if the label is unclear. Keep the answer with the medicine's actual name and route. A broad support promise is less useful than knowing where a question about the prescription will go.
What would make this review more complete
The missing evidence is concrete: a complete ingredient record, identified dispensing pharmacy, actual prescription documentation, and a written cost breakdown. Those records would allow a more precise assessment of the offered preparation without borrowing details from another product.
For now, CoreAge's page supports describing an advertised oral micronized progesterone service with a compounded offering and a starting monthly price. It does not support a claim of superior effectiveness, a guaranteed prescription, or a specific branded capsule. Use that boundary to prepare questions, then let the clinician and pharmacist explain the proposed medicine in terms that match its own records.
Documents behind the details
Read the source for the product, use and context it actually describes. A source type is not a rating of a provider.
- CoreAge Rx: Progesterone OralProvider information · Checked 2026-09-27
- FDA: Prometrium prescribing information, revised February 2026Prescribing information · Checked 2026-09-27
- FDA: Understanding the risks of compounded drugsRegulatory guidance · Checked 2026-09-27
- FDA: Hormone replacement therapies and current label changesRegulatory guidance · Checked 2026-09-27